Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 4, 2015, Pages 698-701

  Sanchez Borges M ^a,b   Caballero Fonseca, F ^b   Capriles Hulett, A ^b   Gonzalez Aveledo L ^b  

^a Clinica El Avila   (Venezuela)

^b Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASPIRIN EXACERBATED SKIN DISEASE; ATOPY; BLOMIA TROPICALIS; CHILD; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SKIN DISEASE; SKIN TEST; CHEMICALLY INDUCED; CHRONIC DISEASE; DISEASE COURSE; DRUG ERUPTIONS; MIDDLE AGED; PHENOTYPE; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; TIME; URTICARIA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE PROGRESSION; DRUG ERUPTIONS; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RESPIRATORY TRACT DISEASES; TIME FACTORS; URTICARIA; YOUNG ADULT;

EID: 84925430829     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12658     Document Type: Article

References (18)

1. Zuberbier T, Aberer W, Asero R, et al,. The EAACI/GA2LEN/EDF/AAAAI/WAO Guideline for the definition, classification, diagnosis and management of Urticaria. The 2013 revision and update. Allergy 2014; 69: 868-887.
2. Moore-Robinson M, Warin RP,. Effect of salicylates in urticaria. Br Med J 1967; 4: 262-264.
3. Kowalski ML, Makowska JS, Blanca M, et al,. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)- classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
4. Sánchez-Borges M,. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 2010; 94: 853-864.
5. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A,. Aspirin-exacerbated cutaneous disease. Immunol Allergy Clin North Am 2013; 33: 251-262.
6. Park HS, Kowalski ML, Sánchez-Borges M,. Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. In, Franklin Adkinson N, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir RE, eds. Middleton's Allergy. Principles and Practice. Elsevier, Philadelphia, 2014: 1296-1309.
7. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A,. Safety of Etoricoxib, a New Cyclooxygenase-2 Inhibitor, in Patients with NSAID-induced Urticaria and Angioedema. Ann Allergy Asthma Immunol 2005; 95: 154-158.
8. Sánchez-Borges M, Capriles-Hulett A,. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84: 101-106.
9. Doeglas HM,. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975; 93: 135-144.
10. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F,. A novel phenotype of NSAID hypersensitivity: the high risk patient. J World Allergy Org 2009; 2: 17-19.
11. Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A,. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase-2 inhibitors. Ann Allergy Asthma Immunol 2005; 94: 34-38.
12. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F,. Increased prevalence of nonsteroidal anti-inflammatory drug hypersensitivity in atopic individuals. Ann Allergy Asthma Immunol 2006; 97: 557.
13. Sánchez-Borges M, Acevedo N, Caraballo L, Capriles-Hulett A, Caballero-Fonseca F,. Increased total and mite-specific IgE in patients with aspirin-induced urticaria and angioedema. J Investig Allergol Clin Immunol 2010; 20: 139-145.
14. Sánchez-Borges M, Fernández-Caldas E, Capriles-Hulett A, Caballero-Fonseca F,. Mite-induced inflammation: more than allergy. Allergy & Rhinology 2012; 3: e25-e29.
15. Isik SR, Karakaya G, Celikel S, Demir AU, Kalyoncu AF,. Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol 2009; 150: 299-306.
16. Kim SH, Ye YM, Palikhe NS,. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010; 10: 280-290.
17. Bae JS, Kim SH, Ye YM,. Significant association of Fc RIa promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007; 119: 449-456.
18. Sánchez-Borges M, Acevedo N, Vergara C, et al,. The A-444C Polymorphism in the Leukotriene C4 Synthase Gene is Associated with Aspirin-induced Urticaria. J Investig Allergol Clin Immunol 2009; 19: 375-382.